APA

Lionetti R., Calvaruso V., Piccolo P., Mancusi R. L., Mazzarelli C., Fagiuoli S., Montalbano M., Lenci I., Carrai P., Guaraldi G., Visco-Comandini U., Milana M., Biolato M., Loiacono L., Valente G., Craxì A., Angelico M. & D'offizi G. (20190528). Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study. : Clinical transplantation.

Chicago

Lionetti Raffaella, Calvaruso Vincenza, Piccolo Paola, Mancusi Rossella Letizia, Mazzarelli Chiara, Fagiuoli Stefano, Montalbano Marzia, Lenci Ilaria, Carrai Paola, Guaraldi Giovanni, Visco-Comandini Ubaldo, Milana Martina, Biolato Marco, Loiacono Laura, Valente Giovanna, Craxì Antonio, Angelico Mario and D'offizi Gianpiero. 20190528. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study. : Clinical transplantation.

Harvard

Lionetti R., Calvaruso V., Piccolo P., Mancusi R. L., Mazzarelli C., Fagiuoli S., Montalbano M., Lenci I., Carrai P., Guaraldi G., Visco-Comandini U., Milana M., Biolato M., Loiacono L., Valente G., Craxì A., Angelico M. and D'offizi G. (20190528). Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study. : Clinical transplantation.

MLA

Lionetti Raffaella, Calvaruso Vincenza, Piccolo Paola, Mancusi Rossella Letizia, Mazzarelli Chiara, Fagiuoli Stefano, Montalbano Marzia, Lenci Ilaria, Carrai Paola, Guaraldi Giovanni, Visco-Comandini Ubaldo, Milana Martina, Biolato Marco, Loiacono Laura, Valente Giovanna, Craxì Antonio, Angelico Mario and D'offizi Gianpiero. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study. : Clinical transplantation. 20190528.